New advances in the pharmacotherapy of multiple sclerosis

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorBegum, Mahamuda
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentMegyeri, Attila
dc.contributor.opponentDrimba, László
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.opponentdeptKenézy Kórház Aneszteziológiai és Intenziv Therápiás Osztályhu_HU
dc.date.accessioned2016-09-16T11:31:25Z
dc.date.available2016-09-16T11:31:25Z
dc.date.created2016
dc.description.abstractDuring the past 10 years there has been developed many different new therapy strategies for treatment of multiple sclerosis. These therapies have been shown increased efficacy compared to previous ones. Several of these new compounds target the inflammatory stage of the disorder by influencing the immune system in different ways. Meanwhile these new drugs are beneficial; it is still challenging to discover therapies for patients suffering from progressive multiple sclerosis. We discuss the present disease modifying-therapies and the new emerging drugs that is used to fight against multiple sclerosis and their mechanism of action.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent34hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/230517
dc.language.isoenhu_HU
dc.subjectMultiple sclerosishu_HU
dc.subjectpharmacotherapyhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleNew advances in the pharmacotherapy of multiple sclerosishu_HU
Fájlok